Application no. and date | 14729687.5 (espacenet) (Federated) (European Patent Register), 20140613 | Patent/reg. no. and date | DK/EP 3010530, 20181226 | Publication date | 20160427 | Priority no. and date | EP 13172341, 20130617, EP 13192556, 20131112 | EP pub. no. and date |
EP 3010530 20160427 | Effective date | | Applicant/owner | Sanofi-Aventis Deutschland GmbH, Brüningstraße 50 65929 Frankfurt am Main, DE | Applicant ref. no. | Sanofi DE2013/136-EP-EPT | Inventor | SOUHAMI, Elisabeth, c/o SANOFI Département Brevets, 54, rue la Boétie
F-75008 Paris, FR, SILVESTRE, Louise, c/o SANOFI Département Brevets, 54, rue la Boétie
F-75008 Paris, FR | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | Opponent | | IPC Class | A61K 38/26 (2006.01) , A61K 38/28 (2006.01) , A61P 3/10 (2006.01) | Title | FORMULERING MED FAST FORHOLD MELLEM INSULIN GLARGIN OG LIXISENATID | Int. application no. | EP2014062418 | Int. publication no. | WO2014202483 | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|